Q2 2026 · Form 13F LedgerData source: SEC EDGAR  
H

HOLDER.TOP

Who owns what — the quarterly ledger of U.S. institutional holdings.
EN · 简 · 繁
Funds / Royalty Pharma Sub-Manager, LLC
Form 13F · Q2 2026

Royalty Pharma Sub-Manager, LLC

CIK 2081668Filed 2026-08-2113F-HR/A View the filing on EDGAR ↗
$242M
Reported book value
4
Positions
3
Quarters on record
Top 50
Positions

Royalty Pharma Sub-Manager, LLC — holdings

Top 4 positions of 4, ranked by reported value. Share change is versus the previous quarter.
#SecuritySharesShare Δ QoQValue% of book
1CYTK Cytokinetics Inc980,392+0.0%$84M34.5%
2ZBIO Zenas Biopharma Inc2.4M+0.0%$61M25.1%
3KLRA Kailera Therapeutics Inc2.5M—$54M22.4%
4BHVN Biohaven Ltd2.9M+0.0%$44M18.1%
Source: Form 13F filings via SEC EDGAR. Positions as of Jun 30, 2026. Options (put/call) are excluded from share counts.